Grants & Programs

Cancer Immunotherapy: Dynamics of Host-Tumor Interaction

September 30, 2013
07:00 AM
Grand Hyatt New York Hotel at Grand Central, New York, NY
View Map

The Cancer Research Institute hosted its 21st Annual International Cancer Immunotherapy Symposium September 30 - October 2, 2013 at The Grand Hyatt in New York City. More than 320 clinicians, laboratory scientists, postdoctoral fellows, and graduate students attended this year's Cancer Immunotherapy 2013: Dynamics of Host-Tumor Interaction, which featured the inaugural William B. Coley keynote lecture by Dr. Michael B. Karin, as well as plenary presentations from leaders in immunology and cancer immunotherapy, a poster session, and numerous networking opportunities.

Our 21st annual symposium focused on the dynamics of host-tumor interaction, with an emphasis on immunological characteristics of the tumor microenvironment, metabolism in the tumor microenvironment, the innate immune response to tumors, and therapeutic applications, including checkpoint blockade, engineered T cells, and vaccination--three of the most exciting areas of cancer treatment today.

Download Final Program (PDF)


Cancer Immunotherapy 2013 Planning Committee

  • James P. Allison, The University of Texas MD Anderson Cancer Center
  • Glenn Dranoff, Dana-Farber Cancer Institute
  • Carl F. Nathan, Weill Cornell Medical College
  • Ellen Puré, The Wistar Institute and University of Pennsylvania
  • Robert D. Schreiber, Washington University School of Medicine
  • Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center